EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access

Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma , decompensation and mortality

Sung Won Lee iD, Daniel Q Huang iD, Ricki Bettencourt, Veeral Ajmera iD, Monica Tincopa iD, Nabil Noureddin, Maral Amangurbanova, Harris Siddiqi, Egbert Madamba, Abdul M Majzoub, Tarek Nayfeh, Nobuharu Tamaki iD und 8 weitere

Alimentary Pharmacology & Therapeutics · 2024

DOI: 10.1111/apt.17783 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2024. Verfasst von Sung Won Lee und 19 weiteren Autor:innen. Beteiligte Einrichtung: NAFLD Research Center, Division of Gastroenterology and Hepatology, University of California at San Diego, La Jolla, California, USA. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Carcinoma, Hepatocellular, Liver Neoplasms, Elasticity Imaging Techniques. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Progression to cirrhosis in non‐alcoholic steatohepatitis (NASH) is associated with a decrease in liver fat. However, the prognostic significance of liver fat content in NASH‐related significant fibrosis and cirrhosis is unclear.

Aim

To investigate the risk of decompensation, hepatocellular carcinoma (HCC) and mortality stratified by liver fat content in NASH‐related significant fibrosis and cirrhosis.

Methods

In this meta‐analysis of individual participant data, 456 patients with both magnetic resonance elastography (MRE) and MRI‐derived protein density fat fraction (MRI‐PDFF) were enrolled, and 296 patients with longitudinal follow‐up were analysed. MRE combined with fibrosis‐4 (MEFIB‐index), and MRI‐PDFF were used to measure liver fibrosis and fat, respectively. MEFIB‐negative, MEFIB‐positive+ MRI‐PDFF ≥5% and MEFIB‐positive+ MRI‐PDFF

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseCarcinoma, HepatocellularLiver NeoplasmsElasticity Imaging TechniquesHumansLiverLiver CirrhosisFibrosisMagnetic Resonance Imaging

Autor:innen und Institutionen

  • NAFLD Research Center, Division of Gastroenterology and Hepatology, University of California at San Diego, La Jolla, California, USA.
  • Division of Hepatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Division of Gastroenterology, University of California at San Diego, La Jolla, California, USA.
  • Evidence-Based Practice Center, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan.

ORCID-Profile: Sung Won Lee, Daniel Q Huang, Veeral Ajmera, Monica Tincopa, Nobuharu Tamaki, Atsushi Nakajima, Rohit Loomba

Förderung

  • NCATS NIH HHS
  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • National Center for Advancing Translational Sciences
  • National Heart, Lung, and Blood Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Lee, S. W., Huang, D. Q., Bettencourt, R., Ajmera, V., Tincopa, M., Noureddin, N., Amangurbanova, M., Siddiqi, H., Madamba, E., Majzoub, A. M., Nayfeh, T., Tamaki, N., Izumi, N., Nakajima, A., Yoneda, M., Idilman, R., Gumussoy, M., Oz, D. K., Erden, A., & Loomba, R. (2024). Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma , decompensation and mortality. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17783

Vancouver

Lee SW, Huang DQ, Bettencourt R, Ajmera V, Tincopa M, Noureddin N, et al. Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma , decompensation and mortality. Alimentary Pharmacology & Therapeutics. 2024. doi:10.1111/apt.17783

BibTeX
@article{Lee2024,
  author = {Lee, Sung Won and Huang, Daniel Q and Bettencourt, Ricki and Ajmera, Veeral and Tincopa, Monica and Noureddin, Nabil and Amangurbanova, Maral and Siddiqi, Harris and Madamba, Egbert and Majzoub, Abdul M and Nayfeh, Tarek and Tamaki, Nobuharu and Izumi, Namiki and Nakajima, Atsushi and Yoneda, Masato and Idilman, Ramzan and Gumussoy, Mesut and Oz, Digdem Kuru and Erden, Ayse and Loomba, Rohit},
  title = {Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma , decompensation and mortality},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2024},
  doi = {10.1111/apt.17783}
}
Kostenlos starten →